Skip to contentA
Axogen, Inc.
A
AXGNAxogen, Inc. Q3 2022 · 10-Q
Revenue$36.96M$36.96M+18.4% vs Q3 2021 Net Income-$4.32M-$4.32MN/M vs Q3 2021 EPS Diluted-$0.10-$0.10N/M vs Q3 2021 Gross Profit$30,783,000+18.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axogen, Inc. · CIK 805928 · Engraved from SEC EDGAR
Operating Cash Flowderived-$689,000N/M Free Cash Flowderived-$5,059,000N/M Margins · derivedGross margin83.3%+0.1 pt vs Q3 2021
Operating margin-13.1%+8.3 pt vs Q3 2021
Net margin-11.7%+11.2 pt vs Q3 2021
ended Sep 30, 2022 · filed Nov 8, 2022 · 39 d after period end